To confirm MEGF10 as an independent predictor with previous widely accepted factors (age, WHO histological grade, and MGMT promoter status), we collected and analyzed the corresponding clinical and molecular information of glioma patients from TCGA datasets. Here, MGMT is linked to glioma.